Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04778410
Title Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications

acute myeloid leukemia

Therapies

Azacitidine + Hu5F9-G4 + Venetoclax

Cytarabine + Etoposide + Hu5F9-G4 + Mitoxantrone

Azacitidine + Hu5F9-G4

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.